A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to assess the effectiveness, safety and tolerability of a range of doses of MK-1602 versus placebo in the treatment of acute migraine.
Epistemonikos ID: aa08dffbdd72965bece0e47560e50ed5d5a2c436
First added on: May 11, 2024